Tracking all-cause mortality at the epicenter of Indonesia's COVID-19 epidemic (TreMOR)

  • Funded by Oxford University Clinical Research Unit (OUCRU)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    -99
  • Known Financial Commitments (USD)

    $0
  • Funder

    Oxford University Clinical Research Unit (OUCRU)
  • Principal Investigator

    N/A

  • Research Location

    Indonesia
  • Lead Research Institution

    N/A
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease transmission dynamics

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Hypothesis There was an association between quantifiable excess mortality and the onset of the COVID-19 epidemic in six urban centers in Indonesia. - Target To estimate excess mortality from the COVID-19 epidemic taking place in six major urban centers in the island of Java. We recommend the following goals: Identify specific government officials - burial or cremation data collectors or others who estimate all-cause mortality and contract them to report the data there for us weekly; Weekly aggregation of all-cause mortality by age and sex for all six cities from January 2017 to date, weekly reporting maintained through March 2021; Weekly aggregation of reported data regarding suspected COVID-19 deaths, along with confirmed COVID-19 cases and confirmed COVID-19 deaths by age and sex count; For each city, calculate the monthly excess of COVID-19 deaths compared with confirmed and suspected COVID-19 deaths; Report these findings to government agencies managing the COVID-19 crisis; Publish these findings monthly in Indonesian on the Indonesian website- The Conversation. Publication of findings during the first 3 months of the epidemic in Indonesia (March, April, May 2020) in a peer-reviewed biomedical journal